Antibacterial Activities Of Bacterial Symbionts
Symbiotic systems often emphasize the importance and biological activities of natural products (NPs) as modulators of symbiont interactions. Such symbioses may be common (both benefiting), commensalist (benefiting just one symbiont), or parasite (benefiting one organism and harming the other), defined as any kind of close , long-term association between both organisms (generally different species). In addition to that, symbiosis can usually be classified either as "obligatory," where each symbiont relies upon the other to survive or as "optional" or facultative. In particular,
model symbiosis can be used from a medicaments discovery point of view to understand aspects related to the development of biosynthetic
gene clusters (BGC) and the use of BGCs in nature. While some symbiotic systems are still too complex to dissect, others provide abundant scientific
information on community shaping as well as ecological justification for drug discovery. Many of the symbiotic systems which are well understood provide insight into how microorganisms such as bacteria and fungi, such as ecologically significant modulate.Thus, a research platform combining ecology,
evolutionary biology, and drug discovery has been established to find antibiotics based on studies on symbiotic relations.
High Impact List of Articles
-
The therapeutic effect of combined therapy of hemopoietin and methylprednisolone in treatment of spinal cord ischemia-reperfusion injury of patient with cervical spondylotic myelopathy and its influence to the level of serum IL-1β, IL-1Ra and IL- 8
Qin Hao, Juan Shen & Lin Zhao
Research Article: Pharmaceutical Bioprocessing
-
The therapeutic effect of combined therapy of hemopoietin and methylprednisolone in treatment of spinal cord ischemia-reperfusion injury of patient with cervical spondylotic myelopathy and its influence to the level of serum IL-1β, IL-1Ra and IL- 8
Qin Hao, Juan Shen & Lin Zhao
Research Article: Pharmaceutical Bioprocessing
-
Analytical models for biopharmaceutical operations and supply chain management
Philip Kaminsky* and Yang Wang
Review Article: Pharmaceutical Bioprocessing
-
Analytical models for biopharmaceutical operations and supply chain management
Philip Kaminsky* and Yang Wang
Review Article: Pharmaceutical Bioprocessing
-
Automation of ELISAs and evaluation of emerging technologies for high throughput quantitation of protein impurities
Hui Cai, Min Guo, Akshit Raj Gupta, William Grimm, Andrea Sease, Richard Rodriguez, Nesredin Mussa* and Zheng Jian Li
Research Article: Pharmaceutical Bioprocessing
-
Automation of ELISAs and evaluation of emerging technologies for high throughput quantitation of protein impurities
Hui Cai, Min Guo, Akshit Raj Gupta, William Grimm, Andrea Sease, Richard Rodriguez, Nesredin Mussa* and Zheng Jian Li
Research Article: Pharmaceutical Bioprocessing
-
Glycosylation analysis of Chinese hamster ovary produced glycoproteins
Maureen Spearman, Edward Bodnar, Helene Perreault and Michael Butler*
Review Article: Pharmaceutical Bioprocessing
-
Glycosylation analysis of Chinese hamster ovary produced glycoproteins
Maureen Spearman, Edward Bodnar, Helene Perreault and Michael Butler*
Review Article: Pharmaceutical Bioprocessing
-
Microbial contamination in industrial animal cell culture operations
Matthew Croughan, Sean Delfosse and Kirilynn Svay
Commentary: Pharmaceutical Bioprocessing
-
Microbial contamination in industrial animal cell culture operations
Matthew Croughan, Sean Delfosse and Kirilynn Svay
Commentary: Pharmaceutical Bioprocessing
Relevant Topics in Clinical